{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"pt-141-ibd","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/pt-141-ibd/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/pt-141-ibd/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"pt-141-ibd","title":"PT-141 for IBD (Crohn's / Colitis): Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:06.983Z","body_excerpt":"## What's breaking down if you have IBD (Crohn's / colitis)\n\nIBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.\n\nLayers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.\n\n## Why PT-141 might help you\n\n1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.\n\n## How these fit together\n\nSingle-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tissue repair or inflammation modulation. PT-141 stands alone here because its documented actions center on arousal circuits rather than primary gut repair.\n\n## What the evidence actually shows\n\nNo human trials test PT-141 in IBD patients (human tier: absent). No rat or mouse studies administer PT-141 in colitis models (preclinical tier: absent for this peptide). A 2023 review examined the broader melanocortin system in IBD using mouse colitis models and noted potential anti-inflammatory roles for related peptides such as α-MSH and KPV (preclinical tier: melanocortin system in general). PT-141 itself receives no mention (source status: unsourced for direct link).\n\n## What scientists say\n\nResearchers describe melanocortin receptor activation as capable of down-regulating NF-κB and certain cytokines in inflamed gut tissue from animal work. They frame this as a possible future direction, not a current therapy. No statements link PT-141 specifically to IBD repair or suppression (mechanistic tier).\n\n## What people say on Reddit\n\nAnecdotal reports of PT-141 use center on sexual function. No widespread IBD-specific threads appear in searched discussions. Isolated mentions treat it as unrelated to bowel inflammation (anecdotal tier: none found).\n\n## What people say on X\n\nPosts discuss PT-141 for arousal or libido. No posts connect it to Crohn's or colitis outcomes. Searches return zero relevant patient experiences (anecdotal tier: none found).\n\n## What we do not know\n\nWhether PT-141 crosses into gut repair pathways at meaningful levels in humans remains unknown. Long-term effects on intestinal inflammation lack any data. Interactions with standard IBD therapies stay unexamined. Human safety in active IBD patients is untested.\n\n## Safety and limits\n\nPT-141 carries documented side effects including nausea and flushing from its approved use in sexual dysfunction. Any extension to IBD would require separate safety evaluation. Current evidence supplies no basis for expecting benefit or ruling out harm in this context (speculative tier for IBD application).","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"No human trials test PT-141 in IBD patients.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct clinical data for the specific pairing.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2","s1"],"source_status":"sourced","why_material":"Separates general melanocortin findings from the peptide in question.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c3","text":"PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair.","tier":"mechanistic","weight":0.3,"section":"Why PT-141 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the if-then logic in known receptor profile without claiming IBD benefit.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10378568/","title":"The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials","quote":"This review summarises the evidence acquired so far and highlights that molecules interfering with the melanocortin system could represent new drugs for treating IBD.","summary":"2023 review of melanocortin system in IBD; mouse models only; no PT-141 data.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"verified","hash":"4b10cbaacb4afae1bd1da37ff3dac24175f77c50ba0980a6fadcc75095102d98"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37508552/","title":"The Melanocortin System in Inflammatory Bowel Diseases","quote":"In the latter context, the system has assumed importance in conditions of chronic digestive inflammation, such as inflammatory bowel diseases (IBD), in which numerous experiences have been accumulated in mouse models of colitis.","summary":"Confirms preclinical focus on related melanocortin peptides, not PT-141.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"8cdf0972935b49f877e2823af29edd5c24c4501a428964636ded0b53548339e8"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women who previously had no problems with sexual desire.","summary":"Official indication confirms CNS/arousal focus.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"f38dd572a4507d682a40693e5941d61c7fb4edd6bf67ce421bc87c8cebff1827"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10378568/","title":"The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials","quote":"This review summarises the evidence acquired so far and highlights that molecules interfering with the melanocortin system could represent new drugs for treating IBD.","summary":"2023 review of melanocortin system in IBD; mouse models only; no PT-141 data.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"verified","hash":"4b10cbaacb4afae1bd1da37ff3dac24175f77c50ba0980a6fadcc75095102d98"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37508552/","title":"The Melanocortin System in Inflammatory Bowel Diseases","quote":"In the latter context, the system has assumed importance in conditions of chronic digestive inflammation, such as inflammatory bowel diseases (IBD), in which numerous experiences have been accumulated in mouse models of colitis.","summary":"Confirms preclinical focus on related melanocortin peptides, not PT-141.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"8cdf0972935b49f877e2823af29edd5c24c4501a428964636ded0b53548339e8"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women who previously had no problems with sexual desire.","summary":"Official indication confirms CNS/arousal focus.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"f38dd572a4507d682a40693e5941d61c7fb4edd6bf67ce421bc87c8cebff1827"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"pt-141-ibd","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":3,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":3,"claims_total":3,"sources":3,"anecdotal":0,"scientific":3,"user_reports":0,"questions":0,"evidence_ingests":0}}